KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Zimmer Biomet Holdings (ZBH) EBITDA (2016 - 2025)

Historic EBITDA for Zimmer Biomet Holdings (ZBH) over the last 17 years, with Q3 2025 value amounting to $351.3 million.

  • Zimmer Biomet Holdings' EBITDA rose 2568.87% to $351.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 653.13%. This contributed to the annual value of $1.3 billion for FY2024, which is 62.61% up from last year.
  • According to the latest figures from Q3 2025, Zimmer Biomet Holdings' EBITDA is $351.3 million, which was up 2568.87% from $300.0 million recorded in Q2 2025.
  • Zimmer Biomet Holdings' 5-year EBITDA high stood at $389.0 million for Q4 2024, and its period low was -$28.3 million during Q4 2022.
  • Moreover, its 5-year median value for EBITDA was $279.5 million (2024), whereas its average is $266.5 million.
  • Its EBITDA has fluctuated over the past 5 years, first plummeted by 12115.1% in 2022, then surged by 135159.01% in 2023.
  • Quarter analysis of 5 years shows Zimmer Biomet Holdings' EBITDA stood at $133.8 million in 2021, then crashed by 121.15% to -$28.3 million in 2022, then skyrocketed by 1351.59% to $354.2 million in 2023, then rose by 9.82% to $389.0 million in 2024, then dropped by 9.69% to $351.3 million in 2025.
  • Its last three reported values are $351.3 million in Q3 2025, $300.0 million for Q2 2025, and $292.3 million during Q1 2025.